Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry.

Vogel B, Chandrasekhar J, Baber U, Mastoris I, Sartori S, Aquino M, Krucoff MW, Moliterno DJ, Henry TD, Weisz G, Gibson CM, Iakovou I, Kini AS, Farhan S, Sorrentino S, Faggioni M, Colombo A, Steg PG, Witzenbichler B, Chieffo A, Cohen DJ, Stuckey T, Ariti C, Dangas GD, Pocock S, Mehran R.

Thromb Haemost. 2019 Jul 31. doi: 10.1055/s-0039-1693463. [Epub ahead of print]

PMID:
31365942
2.

A Randomized, Intercontinental, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with de novo Coronary Artery Lesions BIOFLOW IV - Primary Outcome Target Vessel Failure at 12 Months.

Saito S, Tölg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T.

EuroIntervention. 2019 Jun 25. pii: EIJ-D-18-01214. doi: 10.4244/EIJ-D-18-01214. [Epub ahead of print]

3.

Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention.

Brener SJ, Leon MB, Serruys PW, Smits PC, von Birgelen C, Mehran R, Kirtane AJ, Witzenbichler B, Rinaldi MJ, Metzger DC, Mazzaferri EL Jr, Zhang Z, Stone GW; Collaborators.

EuroIntervention. 2019 Aug 9;15(6):e551-e557. doi: 10.4244/EIJ-D-19-00262.

4.

Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry.

Joyce LC, Baber U, Claessen BE, Sartori S, Chandrasekhar J, Cohen DJ, Henry TD, Ariti C, Dangas G, Faggioni M, Aoi S, Gibson CM, Aquino M, Krucoff MW, Vogel B, Moliterno DJ, Sorrentino S, Colombo A, Chieffo A, Kini A, Guedeney P, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

JACC Cardiovasc Interv. 2019 May 27;12(10):983-992. doi: 10.1016/j.jcin.2019.02.033.

PMID:
31122354
5.

Cardiac Magnetic Resonance Imaging in Patients with Acute Ischemic Stroke and Elevated Troponin: A TRoponin ELevation in Acute Ischemic Stroke (TRELAS) Sub-Study.

Haeusler KG, Jensen C, Scheitz JF, Krause T, Wollboldt C, Witzenbichler B, Audebert HJ, Landmesser U, Fiebach JB, Nolte CH, Endres M, Mochmann HC.

Cerebrovasc Dis Extra. 2019 Apr 30;9(1):19-24. doi: 10.1159/000498864. [Epub ahead of print]

6.

Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.

Faggioni M, Baber U, Sartori S, Chandrasekhar J, Cohen DJ, Henry TD, Claessen BE, Dangas GD, Gibson CM, Krucoff MW, Vogel B, Moliterno DJ, Sorrentino S, Colombo A, Chieffo A, Kini A, Farhan S, Ariti C, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

Circ Cardiovasc Interv. 2019 Apr;12(4):e007133. doi: 10.1161/CIRCINTERVENTIONS.118.007133.

PMID:
30998384
7.

Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.

Finn MT, Redfors B, Karmpaliotis D, Kirtane AJ, Green P, McAndrew T, Liu M, Cloney MB, Witzenbichler B, Weisz G, Stuckey TD, Brodie BR, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Mehran R, Stone GW.

Am Heart J. 2019 May;211:68-76. doi: 10.1016/j.ahj.2019.02.002. Epub 2019 Feb 20.

PMID:
30897527
8.

Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes.

Schoos M, Power D, Baber U, Sartori S, Claessen B, Camaj A, Steg P, Ariti C, Weisz G, Witzenbichler B, Henry T, Cohen D, Antoniucci D, Krucoff M, Hermiller J, Gibson C, Chieffo A, Moliterno D, Colombo A, Pocock S, Dangas G, Mehran R.

Am J Cardiol. 2019 Mar 1;123(5):709-716. doi: 10.1016/j.amjcard.2018.11.051. Epub 2018 Dec 4.

PMID:
30612724
9.

Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry.

Moalem K, Baber U, Chandrasekhar J, Claessen BE, Sartori S, Aquino M, Dangas G, Iakovou I, Colombo A, Kini A, Gibson M, Krucoff M, Chieffo A, Moliterno D, Witzenbichler B, Pocock S, Mehran R.

Clin Res Cardiol. 2019 Jun;108(6):643-650. doi: 10.1007/s00392-018-1392-2. Epub 2019 Jan 3.

PMID:
30607496
10.

Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.

Baber U, Leisman DE, Cohen DJ, Gibson CM, Henry TD, Dangas G, Moliterno D, Kini A, Krucoff M, Colombo A, Chieffo A, Sartori S, Witzenbichler B, Steg PG, Pocock SJ, Mehran R.

Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004945. doi: 10.1161/CIRCOUTCOMES.118.004945.

PMID:
30606052
11.

Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents.

Maehara A, Mintz GS, Witzenbichler B, Weisz G, Neumann FJ, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Stuckey TD, Mazzaferri EL Jr, McAndrew T, Généreux P, Mehran R, Kirtane AJ, Stone GW.

Circ Cardiovasc Interv. 2018 Nov;11(11):e006243. doi: 10.1161/CIRCINTERVENTIONS.117.006243.

PMID:
30571206
12.

Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study).

Rinaldi MJ, Gohs FX, Kirtane AJ, Brodie BR, Stuckey TD, Redfors B, McAndrew T, Witzenbichler B, Weisz G, Neumann FJ, Metzger DC, Maehara A, Généreux P, Mehran R, Stone GW.

Am J Cardiol. 2019 Feb 15;123(4):549-557. doi: 10.1016/j.amjcard.2018.11.026. Epub 2018 Nov 23.

PMID:
30527773
13.

Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.

Brener SJ, Kirtane AJ, Rinaldi MJ, Stuckey TD, Witzenbichler B, Weisz G, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Gurbel PA, Brodie BR, Mehran R, McAndrew T, Stone GW.

Circ Cardiovasc Interv. 2018 Oct;11(10):e006853. doi: 10.1161/CIRCINTERVENTIONS.118.006853.

PMID:
30354629
14.

Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry).

Sorrentino S, Giustino G, Baber U, Sartori S, Cohen DJ, Henry TD, Farhan S, Sharma M, Ariti C, Dangas G, Gibson M, Faggioni M, Krucoff MW, Aquino M, Chandrasekhar J, Moliterno DJ, Colombo A, Vogel B, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

Am J Cardiol. 2018 Nov 15;122(10):1638-1646. doi: 10.1016/j.amjcard.2018.07.041. Epub 2018 Aug 20.

PMID:
30270177
15.

Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents.

Chung CJ, Kirtane AJ, Zhang Y, Witzenbichler B, Weisz G, Stuckey TD, Brodie BR, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Mehran R, Stone GW.

Am Heart J. 2018 Nov;205:77-86. doi: 10.1016/j.ahj.2018.07.020. Epub 2018 Aug 15.

PMID:
30196181
16.

Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation.

Généreux P, Giustino G, Redfors B, Palmerini T, Witzenbichler B, Weisz G, Stuckey TD, Maehara A, Mehran R, Kirtane AJ, Stone GW.

Int J Cardiol. 2018 Oct 1;268:61-67. doi: 10.1016/j.ijcard.2018.03.103.

PMID:
30041804
17.

Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study.

Giustino G, Redfors B, Kirtane AJ, Mehran R, Dangas GD, Witzenbichler B, Neumann FJ, Weisz G, Généreux P, Maehara A, McAndrew T, Farhan S, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Brodie BR, Stuckey TD, Gurbel P, Ben-Yehuda O, Stone GW.

JACC Cardiovasc Interv. 2018 Jul 9;11(13):1277-1286. doi: 10.1016/j.jcin.2018.01.263. Epub 2018 Jun 13.

18.

Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).

Baber U, Li SX, Pinnelas R, Pocock SJ, Krucoff MW, Ariti C, Gibson CM, Steg PG, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Iakovou I, Dangas G, Aquino MB, Sartori S, Chieffo A, Moliterno DJ, Colombo A, Mehran R.

Circ Cardiovasc Interv. 2018 Mar;11(3):e006144. doi: 10.1161/CIRCINTERVENTIONS.117.006144.

PMID:
29870385
19.

Bleeding Severity After Percutaneous Coronary Intervention.

Redfors B, Généreux P, Witzenbichler B, Kirtane AJ, McAndrew T, Weisz G, Stuckey TD, Henry TD, Maehara A, Mehran R, Stone GW.

Circ Cardiovasc Interv. 2018 Mar;11(3):e005542. doi: 10.1161/CIRCINTERVENTIONS.117.005542.

PMID:
29870382
20.

Impact of Routine Invasive Physiology at Time of Angiography in Patients With Multivessel Coronary Artery Disease on Reclassification of Revascularization Strategy: Results From the DEFINE REAL Study.

Van Belle E, Gil R, Klauss V, Balghith M, Meuwissen M, Clerc J, Witzenbichler B, Cercek M, Vlachojannis M, Lang I, Commeau P, Vincent F, Testa L, Wasek W, Debry N, Kische S, Gabrielli G, Sardella G.

JACC Cardiovasc Interv. 2018 Feb 26;11(4):354-365. doi: 10.1016/j.jcin.2017.11.030.

21.

Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study.

Redfors B, Généreux P, Witzenbichler B, Maehara A, Weisz G, McAndrew T, Mehran R, Kirtane AJ, Stone GW.

Am Heart J. 2018 Mar;197:142-149. doi: 10.1016/j.ahj.2017.11.011. Epub 2017 Dec 5.

PMID:
29447774
22.

Percutaneous coronary intervention of bifurcation lesions and platelet reactivity.

Redfors B, Généreux P, Witzenbichler B, Kirtane AJ, Maehara A, Weisz G, Madhavan MV, McAndrew T, Mehran R, Stone GW.

Int J Cardiol. 2018 Jan 1;250:92-97. doi: 10.1016/j.ijcard.2017.10.022. Epub 2017 Oct 7.

PMID:
29074039
23.

White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry).

Shah B, Baber U, Pocock SJ, Krucoff MW, Ariti C, Gibson CM, Steg PG, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Iakovou I, Dangas G, Aquino MB, Sartori S, Chieffo A, Moliterno DJ, Colombo A, Mehran R.

Circ Cardiovasc Interv. 2017 Sep;10(9). pii: e004981. doi: 10.1161/CIRCINTERVENTIONS.117.004981.

24.

Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.

Giustino G, Redfors B, Mehran R, Kirtane AJ, Baber U, Généreux P, Witzenbichler B, Neumann FJ, Weisz G, Maehara A, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Brodie BR, Stuckey TD, Dangas GD, Brener SJ, Ozgu Ozan M, Stone GW.

Int J Cardiol. 2017 Nov 1;246:20-25. doi: 10.1016/j.ijcard.2017.05.091.

PMID:
28867009
25.

Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy.

Shan P, Mintz GS, Witzenbichler B, Metzger DC, Rinaldi MJ, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Généreux P, Crowley A, Kirtane AJ, Stone GW, Maehara A.

Int J Cardiol. 2017 Dec 1;248:97-102. doi: 10.1016/j.ijcard.2017.08.028. Epub 2017 Aug 12.

PMID:
28818353
26.

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.

Stuckey TD, Kirtane AJ, Brodie BR, Witzenbichler B, Litherland C, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Gurbel PA, Mehran R, Généreux P, Ben-Yehuda O, Simonton CA, Stone GW; ADAPT-DES Investigators.

JACC Cardiovasc Interv. 2017 Aug 28;10(16):1607-1617. doi: 10.1016/j.jcin.2017.05.059. Epub 2017 Aug 2.

27.

Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry).

Schoos M, Chandrasekhar J, Baber U, Bhasin A, Sartori S, Aquino M, Vogel B, Farhan S, Sorrentino S, Kini A, Kruckoff M, Moliterno D, Henry TD, Weisz G, Gibson CM, Iakovou I, Colombo A, Steg PG, Witzenbichler B, Chieffo A, Cohen D, Stuckey T, Ariti C, Dangas G, Pocock S, Mehran R.

Am J Cardiol. 2017 Sep 15;120(6):904-910. doi: 10.1016/j.amjcard.2017.06.016. Epub 2017 Jun 28.

28.

Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study).

Redfors B, Ben-Yehuda O, Lin SH, Furer A, Kirtane AJ, Witzenbichler B, Weisz G, Stuckey TD, Maehara A, Généreux P, Giustino G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Ayele GM, Mehran R, Mintz GS, Stone GW.

Am J Cardiol. 2017 Sep 15;120(6):917-923. doi: 10.1016/j.amjcard.2017.06.019. Epub 2017 Jun 28.

PMID:
28754568
29.

Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation.

Redfors B, Maehara A, Witzenbichler B, Weisz G, Stuckey TD, Henry TD, McAndrew T, Mehran R, Kirtane AJ, Stone GW, Généreux P.

J Invasive Cardiol. 2017 Nov;29(11):378-386. Epub 2017 Jun 15.

30.

Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry.

Chandrasekhar J, Baber U, Sartori S, Aquino M, Tomey M, Kruckoff M, Moliterno D, Henry TD, Weisz G, Gibson CM, Iakovou I, Kini A, Faggioni M, Vogel B, Farhan S, Colombo A, Steg PG, Witzenbichler B, Chieffo A, Cohen D, Stuckey T, Ariti C, Pocock S, Dangas G, Mehran R.

Int J Cardiol. 2017 Sep 15;243:132-139. doi: 10.1016/j.ijcard.2017.05.049. Epub 2017 May 12.

PMID:
28554669
31.

Percutaneous Coronary Intervention of Saphenous Vein Graft.

Redfors B, Généreux P, Witzenbichler B, McAndrew T, Diamond J, Huang X, Maehara A, Weisz G, Mehran R, Kirtane AJ, Stone GW.

Circ Cardiovasc Interv. 2017 May;10(5). pii: e004953. doi: 10.1161/CIRCINTERVENTIONS.117.004953.

PMID:
28495896
32.

Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials).

Brener SJ, Mehran R, Dangas GD, Ohman EM, Witzenbichler B, Zhang Y, Parvataneni R, Stone GW.

Am J Cardiol. 2017 Jun 1;119(11):1710-1716. doi: 10.1016/j.amjcard.2017.02.052. Epub 2017 Mar 16.

PMID:
28388994
33.

Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry.

Faggioni M, Baber U, Sartori S, Giustino G, Cohen DJ, Henry TD, Farhan S, Ariti C, Dangas G, Gibson M, Giacoppo D, Krucoff MW, Aquino M, Chandrasekhar J, Moliterno DJ, Colombo A, Vogel B, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

JACC Cardiovasc Interv. 2017 Apr 10;10(7):645-654. doi: 10.1016/j.jcin.2016.12.003. Epub 2017 Mar 15.

34.

Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).

Gupta R, Kirtane AJ, Ozan MO, Witzenbichler B, Rinaldi MJ, Metzger DC, Weisz G, Stuckey TD, Brodie BR, Mehran R, Ben-Yehuda O, Stone GW.

Circ Cardiovasc Interv. 2017 Mar;10(3). pii: e004904. doi: 10.1161/CIRCINTERVENTIONS.116.004904.

PMID:
28288963
35.

Impact of chronic statin therapy on clinical presentation and underlying lesion morphology in patients undergoing percutaneous intervention: an ADAPT-DES IVUS substudy.

Kadohira T, Mintz GS, Souza CF, Witzenbichler B, Metzger DC, Rinaldi MJ, Mazzaferri EL Jr, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Crowley A, Kirtane AJ, Stone GW, Maehara A.

Coron Artery Dis. 2017 May;28(3):218-224. doi: 10.1097/MCA.0000000000000480.

PMID:
28240675
36.

Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).

Yu J, Mehran R, Baber U, Ooi SY, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Brodie BR, Stuckey TD, Maehara A, Xu K, Ben-Yehuda O, Kirtane AJ, Stone GW.

Circ Cardiovasc Interv. 2017 Feb;10(2). pii: e003577. doi: 10.1161/CIRCINTERVENTIONS.116.003577.

PMID:
28193677
37.

Comparison of plaque morphology between peripheral and coronary artery disease (from the CLARITY and ADAPT-DES IVUS substudies).

Yin D, Matsumura M, Rundback J, Yoho JA, Witzenbichler B, Stone GW, Mintz GS, Maehara A.

Coron Artery Dis. 2017 Aug;28(5):369-375. doi: 10.1097/MCA.0000000000000469.

PMID:
28118185
38.

Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents.

Généreux P, Redfors B, Witzenbichler B, Arsenault MP, Weisz G, Stuckey TD, Rinaldi MJ, Neumann FJ, Christopher Metzger D, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Francese DP, Marquis-Gravel G, Mintz GS, Kirtane AJ, Maehara A, Mehran R, Stone GW.

Int J Cardiol. 2017 Mar 15;231:61-67. doi: 10.1016/j.ijcard.2016.12.150. Epub 2016 Dec 26.

PMID:
28040289
39.

Predictors and Long-Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Intravascular Ultrasound Substudy.

Wang B, Mintz GS, Witzenbichler B, Souza CF, Metzger DC, Rinaldi MJ, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Matsumura M, Yamamoto MH, Parvataneni R, Kirtane AJ, Stone GW, Maehara A.

J Am Heart Assoc. 2016 Dec 22;5(12). pii: e004438. doi: 10.1161/JAHA.116.004438.

40.

Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes.

Schoos MM, Mehran R, Dangas GD, Yu J, Baber U, Clemmensen P, Feit F, Gersh BJ, Guagliumi G, Ohman EM, Pocock SJ, Witzenbichler B, Stone GW.

Am J Cardiol. 2016 Dec 1;118(11):1661-1668. doi: 10.1016/j.amjcard.2016.08.046. Epub 2016 Oct 11.

PMID:
27836132
41.

Relation Between Renal Function and Coronary Plaque Morphology (from the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Virtual Histology-Intravascular Ultrasound Substudy).

Chin CY, Mintz GS, Saito S, Witzenbichler B, Metzger DC, Rinaldi MJ, Mazzaferri EL Jr, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Litherland C, Kirtane AJ, Stone GW, Maehara A.

Am J Cardiol. 2017 Jan 15;119(2):217-224. doi: 10.1016/j.amjcard.2016.09.050. Epub 2016 Oct 7.

PMID:
27814787
42.

Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.

Chandrasekhar J, Bansilal S, Baber U, Sartori S, Aquino M, Farhan S, Vogel B, Faggioni M, Giustino G, Ariti C, Colombo A, Chieffo A, Kini A, Saporito R, Michael Gibson C, Witzenbichler B, Cohen D, Moliterno D, Stuckey T, Henry T, Pocock S, Dangas G, Gabriel Steg P, Mehran R.

Catheter Cardiovasc Interv. 2017 Jun 1;89(7):E217-E225. doi: 10.1002/ccd.26716. Epub 2016 Sep 21.

PMID:
27650638
43.

Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy.

Qiu F, Mintz GS, Witzenbichler B, Metzger DC, Rinaldi MJ, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Parvataneni R, Kirtane AJ, Stone GW, Maehara A.

JACC Cardiovasc Interv. 2016 Jul 25;9(14):1499-507. doi: 10.1016/j.jcin.2016.05.043.

44.

Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents.

Yu J, Baber U, Mastoris I, Dangas G, Sartori S, Steg PG, Cohen DJ, Giustino G, Chandrasekhar J, Ariti C, Witzenbichler B, Henry TD, Kini AS, Krucoff MW, Gibson CM, Chieffo A, Moliterno DJ, Colombo A, Pocock S, Mehran R.

JACC Cardiovasc Interv. 2016 Jul 25;9(14):1461-9. doi: 10.1016/j.jcin.2016.04.004.

45.

Prevalence, Features, and Prognostic Importance of Edge Dissection After Drug-Eluting Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy.

Kobayashi N, Mintz GS, Witzenbichler B, Metzger DC, Rinaldi MJ, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Parvataneni R, Kirtane AJ, Stone GW, Maehara A.

Circ Cardiovasc Interv. 2016 Jul;9(7):e003553. doi: 10.1161/CIRCINTERVENTIONS.115.003553.

PMID:
27402854
46.

Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry.

Baber U, Dangas G, Chandrasekhar J, Sartori S, Steg PG, Cohen DJ, Giustino G, Ariti C, Witzenbichler B, Henry TD, Kini AS, Krucoff MW, Gibson CM, Chieffo A, Moliterno DJ, Weisz G, Colombo A, Pocock S, Mehran R.

JACC Cardiovasc Interv. 2016 Jul 11;9(13):1349-57. doi: 10.1016/j.jcin.2016.04.009.

47.

The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study.

Brener SJ, Kirtane AJ, Stuckey TD, Witzenbichler B, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Mehran R, Parvataneni R, Brodie BR, Stone GW.

JACC Cardiovasc Interv. 2016 Jul 25;9(14):1450-7. doi: 10.1016/j.jcin.2016.04.037. Epub 2016 Jun 29.

48.

Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.

Giustino G, Kirtane AJ, Baber U, Généreux P, Witzenbichler B, Neumann FJ, Weisz G, Maehara A, Rinaldi MJ, Metzger C, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Brodie BR, Stuckey TD, Gurbel PA, Dangas GD, Francese DP, Ozan O, Mehran R, Stone GW.

Am J Cardiol. 2016 Jun 15;117(12):1877-83. doi: 10.1016/j.amjcard.2016.03.034. Epub 2016 Apr 6.

PMID:
27131611
49.

Impact of an integrated treatment algorithm based on platelet function testing and clinical risk assessment: results of the TRIAGE Patients Undergoing Percutaneous Coronary Interventions To Improve Clinical Outcomes Through Optimal Platelet Inhibition study.

Chandrasekhar J, Baber U, Mehran R, Aquino M, Sartori S, Yu J, Kini A, Sharma S, Skurk C, Shlofmitz RA, Witzenbichler B, Dangas G.

J Thromb Thrombolysis. 2016 Aug;42(2):186-96. doi: 10.1007/s11239-016-1357-0.

PMID:
27100112
50.

Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.

Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, Kirtane AJ, Stone GW, Colombo A, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S.

J Am Coll Cardiol. 2016 May 17;67(19):2224-2234. doi: 10.1016/j.jacc.2016.02.064. Epub 2016 Apr 11.

Supplemental Content

Loading ...
Support Center